Antibodies after Botulinum Toxin A Injection into Musculus Detrusor Vesicae: Incidence and Clinical Relevance
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibodies after Botulinum Toxin A Injection into Musculus Detrusor Vesicae: Incidence and Clinical Relevance
Authors
Keywords
-
Journal
UROLOGIA INTERNATIONALIS
Volume 87, Issue 4, Pages 439-444
Publisher
S. Karger AG
Online
2011-11-01
DOI
10.1159/000332194
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adverse Events of Intravesical Botulinum Toxin A Injections for Idiopathic Detrusor Overactivity: Risk Factors and Influence on Treatment Outcome
- (2010) Hann-Chorng Kuo et al. EUROPEAN UROLOGY
- Emerging drugs for treatment of urinary incontinence
- (2010) Monika Vij et al. EXPERT OPINION ON EMERGING DRUGS
- Outcomes of Intravesical Botulinum Toxin for Idiopathic Overactive Bladder Symptoms: A Systematic Review of the Literature
- (2010) Jennifer T. Anger et al. JOURNAL OF UROLOGY
- Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia
- (2010) Daniel Truong et al. PARKINSONISM & RELATED DISORDERS
- Wirkung von Botulinumtoxin A in der ein- und mehrmaligen Behandlung der überaktiven Blase
- (2010) C. Frohme et al. UROLOGE
- Current Information on Sacral Neuromodulation and Botulinum Toxin Treatment for Refractory Idiopathic Overactive Bladder Syndrome: A Review
- (2010) Randall K. Leong et al. UROLOGIA INTERNATIONALIS
- Antibody Formation Following Botulinum Toxin Type A (Dysport) Injection in Children With Intractable Bladder Hyper-reflexia
- (2010) Abdol-Mohammad Kajbafzadeh et al. UROLOGY
- Neutralizing Antibodies and Secondary Therapy Failure After Treatment With Botulinum Toxin Type A
- (2009) Oliver Lange et al. CLINICAL NEUROPHARMACOLOGY
- Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence
- (2009) Karl-Erik Andersson et al. CURRENT OPINION IN UROLOGY
- Prevalence of neutralising antibodies in patients treated with botulinum toxin type A for spasticity
- (2009) Kerstin Müller et al. JOURNAL OF NEURAL TRANSMISSION
- Treatment of Neurogenic Detrusor Overactivity with Botulinum Toxin A: The First Seven Years
- (2009) Manfred Stoehrer et al. UROLOGIA INTERNATIONALIS
- Repeated Injections of Botulinum Toxin-A for Idiopathic Detrusor Overactivity
- (2009) Arun Sahai et al. UROLOGY
- Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity
- (2008) D.M. Schmid et al. BJU INTERNATIONAL
- Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report
- (2008) Apostolos Apostolidis et al. EUROPEAN UROLOGY
- Botulinum neurotoxin type A in urology: Antibodies as a cause of therapy failure
- (2008) Heinrich Schulte-Baukloh et al. INTERNATIONAL JOURNAL OF UROLOGY
- Botulinum toxin-A for idiopathic overactivity of the vesical detrusor: a 2-year follow-up
- (2008) Stefanie Kuschel et al. INTERNATIONAL UROGYNECOLOGY JOURNAL
- Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay
- (2008) Mitchell F. Brin et al. MOVEMENT DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search